KRISTINE ILGENFRITZ: Open Payments
NPI 1144382623 · LAKE MARY, FL. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$843 in 54 payments from 12 companies in 2025. Trend: 2023 $120 · 2024 $642 · 2025 $843
Food & beverage: $843
| Company | Payments | Amount |
|---|---|---|
| Novo Nordisk Inc | 16 | $281 |
| Amgen Inc. | 17 | $172 |
| Lilly USA, LLC | 4 | $61 |
| AstraZeneca Pharmaceuticals LP | 3 | $59 |
| Astellas Pharma US Inc | 3 | $54 |
| GlaxoSmithKline, LLC. | 3 | $48 |
| Abbott Laboratories | 2 | $47 |
| ABBVIE INC. | 2 | $30 |
| Azurity Pharmaceuticals, Inc. | 1 | $28 |
| PhotoniCare Inc | 1 | $22 |
Products named: OTEZLA, Ozempic, Wegovy, Rybelsus, MOUNJARO, Veozah, TRELEGY ELLIPTA, FREESTYLE LIBRE 3.
Industry payments across FL — which companies pay providers there.
